U.S. justices wary of wide human gene patent ruling

By Lawrence Hurley WASHINGTON (Reuters) – U.S. Supreme Court justices on Monday signaled reluctance to issue too broad a ruling about patents on human genes, and some indicated they might seek a compromise distinguishing between types of genetic material. The biotechnology industry has warned that an expansive ruling against Myriad Genetics Inc could threaten billions of dollars of investment. …